Dr. Jacob Frenkel
Board Member
Brainstorm Cell Therapeutics Inc. (BCLI)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Jacob Frenkel
Dr. Jacob Frenkel is recorded as Board Member at Brainstorm Cell Therapeutics Inc. (BCLI). Brainstorm Cell Therapeutics Inc. reported in an 8-K filed July 30, 2026 that Dr. Jacob Frenkel resigned as Chairman of the Board, effective July 24, 2026. Brainstorm Cell Therapeutics Inc. reported in an 8-K filed July 30, 2026 that Dr. Jacob Frenkel resigned as director, effective July 24, 2026. Brainstorm Cell Therapeutics Inc. reported in an 8-K filed September 16, 2024 that Dr. Jacob Frenkel was appointed Director, effective September 16, 2024.
“Jacob Frenkel, Ph.D., resigned as Chairman of the Board and as a director on July 24, 2026.”
“Jacob Frenkel, Ph.D., resigned as Chairman of the Board and as a director on July 24, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-09-16–present
-
2025-06-25–2026-07-24
-
Start not stated–2026-07-24
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Brainstorm Cell Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Mr. Chaim Lebovits CEO
- Jacob A. Frenkel Chairman, Board Member
- Peter J. Pitts Chairman, Board Member
- Peter Pitts Chairman, Board Member
- Ms. Alla Patlis CFO
- Dr. Hartoun Hartounian COO
- Dr. Anthony Polverino Board Member
- Dr. Irit Arbel Board Member
- Dr. Menghisteab Bairu Board Member
- Dr. Stacy Lindborg Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.